How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development. Cell Medica has bought Catapult Therapy TCR for its clinical-phase WT1 T-cell receptor cell therapy.

With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.

European scientists tested a vaccine to inhibit the cholesterol-related enzyme PCSK9 and reported promising results in mice. ReWalk Robotics, which makes an how to sell ipo shares in singapore for people with spinal cord injury, unveiled a soft version designed for stroke survivors.

A new molecule may shed light on how synaptic imbalances happen and improve understanding of neurological conditions.

Skip forex momentum divergence indicator main content document. Sarepta signs how to sell ipo shares in singapore Duchenne gene therapy pact by Ben Adams.

Cash-strapped ImmunoCellular halts brain cancer vaccine trial by Phil Taylor.

Merck Ventures, CRUK launch new I-O spinout biotech iOnctura. Sponsored by PAREXEL Jun 1, 3: Cell Medica buys clinical-phase WT1-TCR cell therapy.

Applying for an IPO? Read this

The Impact of Data and Informatics Technologies Throughout the Clinical Trial Journey. Sponsored by Covance May 18, 1: Novartis' longer-acting AMD drug matches Eylea in phase 3 trials.

FAQs - Electronic Security Application | DBS Bank Singapore

Anti-PCSK9 vaccine lowers cholesterol, atherosclerosis in mice. ReWalk Robotics debuts soft suit exoskeleton for stroke patients.

New protein could unravel the causes of some brain disorders.